# Patient Care Plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Mark Twain (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI013-SYN-TD
- Date: 1905-06-12
- Fictional facility: St. Posthumous Health Center
- Fictional author: Winifred Achterberg-Lowe, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

## What we are working on

- He says the year since his wife died has not softened anything, and he wants to be able to work and see his friends again **S**
- He does not want to give up cigars, which he says help him write, but worries about his heart **S**
- He wants the gout attacks to stop **S**

## Your goals

- PG-13-R below 30 and back to writing and seeing friends. Target: 1905-10-16. Recorded outcome: PG-13-R 41 at intake to 26 at eighteen weeks; finishing a long essay; dinner with friends weekly. **S**
- No thoughts of death and a safety plan he would use. Target: 1905-09-11. Recorded outcome: Passive thoughts of death at intake; none since the five-week visit; safety plan kept. **S**
- Stop smoking cigars. Target: 1905-10-16. Recorded outcome: Fifteen cigars a day at intake; quit in the first week of August with varenicline; one lapse of two cigars while away; none for eight weeks. **S**
- LDL cholesterol at least 50 percent lower on a high-intensity statin. Target: 1905-09-11. Recorded outcome: LDL 150 to 74 mg/dL (51 percent lower) at eight weeks. **S**
- Serum urate below 6 mg/dL and no gout flares. Target: 1905-10-16. Recorded outcome: Urate 8.6, 7.4 and 6.4 mg/dL; one flare in August, treated while away; allopurinol raised to 300 mg. **S**
- Six or more hours of sleep on most nights without a sleeping pill. Target: 1905-10-16. Recorded outcome: About four to five hours at intake; six hours on most nights by eighteen weeks. **S**

## What we agreed to do

- Geriatric psychiatry consultation to confirm the diagnosis, separate prolonged grief disorder from major depression, advise on grief therapy, medicine and sleep, and review suicide risk. Guideline: Prolonged Grief Disorder (DSM-5-TR criteria, patient and family information) (2022); Validation of the new DSM-5-TR criteria for prolonged grief disorder and the PG-13-Revised (PG-13-R) scale (2021); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024) **S**
- Safety: a structured safety assessment, a written safety plan, the 988 Suicide & Crisis Lifeline in his phone, means safety, a telephone call in three days, and safety review at every visit. Guideline: Loss of partner and suicide risks among oldest old: a population-based register study (2004); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, ischemic heart disease, hyperlipidemia, and depression, bipolar, and mood disorders monographs (2026) **S**
- Prolonged grief disorder therapy (Shear): sixteen weekly sessions with a trained psychologist, covering the story of the death, imaginal conversations with his wife, memories and pictures, revisiting avoided places and things, and personal goals; PG-13-R and PHQ-9 every four weeks; no antidepressant unless major depression develops. Guideline: Prolonged Grief Disorder (DSM-5-TR criteria, patient and family information) (2022); Validation of the new DSM-5-TR criteria for prolonged grief disorder and the PG-13-Revised (PG-13-R) scale (2021); Treatment of complicated grief: a randomized controlled trial (2005); Optimizing Treatment of Complicated Grief: A Randomized Clinical Trial (2016) **S**
- Sleep: a fixed rising time, no naps after noon, no cigar or whisky in the last hours before bed, and getting up if awake more than twenty minutes; no benzodiazepine, zolpidem or sedating antihistamine. Guideline: Optimizing Treatment of Complicated Grief: A Randomized Clinical Trial (2016); CMID: Clinical Monitoring Intelligence Database, ischemic heart disease, hyperlipidemia, and depression, bipolar, and mood disorders monographs (2026) **S**
- Tobacco: his readiness asked at every visit; brief advice linked to his own concern about his heart; counseling at each visit and the state quitline; varenicline offered as the most effective single medicine, with combination nicotine replacement as the alternative. Guideline: Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021) **S**
- Chest tightness on exertion: resting ECG today and CT coronary angiography, chosen over stress testing for a man over 65 with stable symptoms and no known coronary disease; call 911 for chest pain at rest or lasting more than fifteen minutes. Guideline: 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain (2021) **S**
- Nonobstructive coronary disease: atorvastatin 40 mg with a lipid panel 4 to 12 weeks later and a goal of at least a 50 percent fall in LDL, aspirin 81 mg, blood pressure below 130/80 mmHg, stopping smoking, and walking most days. Guideline: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (2023); CMID: Clinical Monitoring Intelligence Database, ischemic heart disease, hyperlipidemia, and depression, bipolar, and mood disorders monographs (2026) **S**
- Gout: allopurinol from 100 mg daily, raised by 100 mg every two to five weeks to a serum urate below 6 mg/dL, with colchicine 0.6 mg daily for three to six months to prevent flares; flares treated without stopping allopurinol; HLA-B*58:01 testing not indicated by ancestry; less alcohol. Guideline: 2020 American College of Rheumatology Guideline for the Management of Gout (2020) **S**
- Social connection and his writing: one planned social contact a week, a return to morning writing on a set project, and the clinic social worker's list of local groups; meaning and goals to be part of any grief treatment. Guideline: Treatment of complicated grief: a randomized controlled trial (2005) **S**
- Gout: urate measured at intake; urate-lowering therapy explained, since two flares in a year make it strongly recommended; he chose to decide after the chest evaluation; call at the first sign of a flare. Guideline: 2020 American College of Rheumatology Guideline for the Management of Gout (2020) **S**
- Cardiovascular risk: blood pressure at each visit and lipids, hemoglobin A1c and kidney function at baseline; prediabetes (hemoglobin A1c 5.8 percent) managed with walking and diet. Guideline: 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain (2021); CMID: Clinical Monitoring Intelligence Database, ischemic heart disease, hyperlipidemia, and depression, bipolar, and mood disorders monographs (2026) **S**

## Follow-up

- 1905-06-12: Establishing primary care a year after his wife's death: yearning, poor sleep, low mood and withdrawal, suicide risk, heavy cigar smoking, chest tightness on hills, gout and cardiovascular risk **S**
- 1905-06-19: One-week review, seen the same day by geriatric psychiatry: the diagnosis of prolonged grief disorder, grief therapy, sleep and safety **S**
- 1905-07-17: Five-week review: CT coronary angiography result, a statin and aspirin, a plan to quit smoking, and starting allopurinol **S**
- 1905-09-11: Thirteen-week review: grief therapy, smoking, a gout flare while away, the urate and lipid results **S**
- 1905-09-25: Subsequent annual wellness visit **S**
- 1905-10-16: Eighteen-week review: grief, no smoking, urate toward target and his writing **S**

This teaching document does not replace care from a qualified clinician.
